• Deep dive into business development in biotech with James Lee

  • Jan 18 2024
  • Durée: 29 min
  • Podcast

Deep dive into business development in biotech with James Lee

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • Business development is an essential process for biotech companies to build relationships with partners and create value from the deal structures that are based on science. We are taking a deep dive with James Lee into the mechanics and the framework that James uses for business development. 

    James founded Bridge Biotherapeutics Inc. in 2015 and he currently serves as the CEO. Bridge has been recognized with the continuous advancement of clinical-stage programs focused on pulmonary fibrosis, lung cancer, and immunology. In 2019, James successfully orchestrated the licensing-out deal with Boehringer Ingelheim, which marked as one of the largest global deals on a single compound in Korea.
    Voir plus Voir moins
Voir plus Voir moins

Ce que les auditeurs disent de Deep dive into business development in biotech with James Lee

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.